Lista de obras -

A Genome-Wide Assessment of Variability in Human Serum Metabolism

article

A Germline DNA Polymorphism Enhances Alternative Splicing of theKLF6Tumor Suppressor Gene and Is Associated with Increased Prostate Cancer Risk

article

A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants

scientific journal article

A genome-wide survey over the ChIP-on-chip identified androgen receptor-binding genomic regions identifies a novel prostate cancer susceptibility locus at 12q13.13.

artículo científico publicado en 2011

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

artículo científico publicado en 2014

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease

artículo científico publicado en 2012

A multigenic approach to evaluating prostate cancer risk in a systematic replication study

artículo científico publicado en 2008

A novel prostate cancer susceptibility locus at 19q13

artículo científico publicado en 2009

Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial

artículo científico publicado en 2016

Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease

artículo científico publicado en 2013

Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans

artículo científico publicado en 2008

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

artículo científico publicado en 2007

Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer

artículo científico publicado en 2009

Association of prostate cancer risk with SNPs in regions containing androgen receptor binding sites captured by ChIP-On-chip analyses

artículo científico publicado en 2011

Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer

artículo científico publicado en 2009

Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG

artículo científico publicado en 2011

Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk

artículo científico publicado en 2003

Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer

scientific journal article

Comparison of two methods for estimating absolute risk of prostate cancer based on single nucleotide polymorphisms and family history

artículo científico publicado en 2010

Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk: strong confirmation of functional promoter SNP.

artículo científico publicado en 2005

Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations

artículo científico publicado en 2008

Estimation of absolute risk for prostate cancer using genetic markers and family history

artículo científico publicado en 2009

Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer ⬇️

artículo científico publicado el 15 de junio de 2003

Family-based samples can play an important role in genetic association studies

artículo científico publicado en 2008

Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk

scientific article published on 19 January 2009

Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11.

artículo científico publicado en 2009

Generalizability of established prostate cancer risk variants in men of African ancestry

artículo científico publicado en 2014

Genetic markers associated with early cancer-specific mortality following prostatectomy

artículo científico publicado en 2013

Genetic variants and family history predict prostate cancer similar to prostate-specific antigen

artículo científico publicado en 2009

Genetic variation in the upstream region of ERG and prostate cancer

artículo científico publicado en 2009

Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.

artículo científico publicado en 2016

Genome-wide association study identifies a new locus JMJD1C at 10q21 that may influence serum androgen levels in men.

artículo científico publicado en 2012

Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21.

artículo científico publicado en 2011

Genome-wide copy-number variation analysis identifies common genetic variants at 20p13 associated with aggressiveness of prostate cancer

artículo científico publicado en 2011

Genome-wide screen for prostate cancer susceptibility genes in men with clinically significant disease.

artículo científico publicado en 2005

Genome‐wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families ⬇️

artículo científico publicado el 1 de diciembre de 2003

Germ-line sequence variants of PTEN do not have an important role in hereditary and non-hereditary prostate cancer susceptibility

artículo científico publicado en 2011

Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer

scientific article published on 08 October 2018

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death

artículo científico publicado en 2016

Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk

artículo científico publicado en 2002

Germline mutations in HOXB13 and prostate-cancer risk

artículo científico publicado en 2012

H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer

artículo científico publicado en 2004

Identification of a new prostate cancer susceptibility locus on chromosome 8q24.

artículo científico publicado en 2009

Identification of a novel NBN truncating mutation in a family with hereditary prostate cancer ⬇️

artículo científico publicado en 2012

Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families

artículo científico publicado en 2004

Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients

artículo científico publicado en 2009

Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer

artículo científico publicado en 2010

Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions

artículo científico publicado en 2015

Interaction effect of PTEN and CDKN1B chromosomal regions on prostate cancer linkage

artículo científico publicado en 2004

Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk

artículo científico publicado en 2006

Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial

artículo científico publicado en 2016

Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer

artículo científico publicado en 2015

Large-scale fine mapping of the HNF1B locus and prostate cancer risk

artículo científico publicado en 2011

MP69-12 ADDED VALUE OF GENETIC RISK SCORE TO THE PROSTATE CANCER PREVENTION TRIAL (PCPT) RISK CALCULATOR: FINDINGS FROM THE PCPT STUDY

Mutational analysis of PINX1 in hereditary prostate cancer.

artículo científico publicado en 2004

Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial

artículo científico publicado en 2012

Prostate Cancer Susceptibility in Men of African Ancestry at 8q24

artículo científico publicado en 2016

Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic Variation

artículo científico publicado en 2010

Sequence variants in the 3'-->5' deoxyribonuclease TREX2: identification in a genetic screen and effects on catalysis by the recombinant proteins

artículo científico publicado en 2004

Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study

artículo científico publicado en 2004

Systematic replication study of reported genetic associations in prostate cancer: Strong support for genetic variation in the androgen pathway

artículo científico publicado en 2006

The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk

artículo científico publicado en 2005

Two independent prostate cancer risk-associated Loci at 11q13

artículo científico publicado en 2009

Two susceptibility loci identified for prostate cancer aggressiveness

artículo científico publicado en 2015

Two-locus genome-wide linkage scan for prostate cancer susceptibility genes with an interaction effect

article

Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG)

artículo científico publicado en 2011

Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial

artículo científico publicado en 2015

Lista de obras de

A Genome-Wide Assessment of Variability in Human Serum Metabolism

A Germline DNA Polymorphism Enhances Alternative Splicing of theKLF6Tumor Suppressor Gene and Is Associated with Increased Prostate Cancer Risk

A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants

A genome-wide survey over the ChIP-on-chip identified androgen receptor-binding genomic regions identifies a novel prostate cancer susceptibility locus at 12q13.13.

A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer

A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease

A multigenic approach to evaluating prostate cancer risk in a systematic replication study

A novel prostate cancer susceptibility locus at 19q13

Adding genetic risk score to family history identifies twice as many high-risk men for prostate cancer: Results from the prostate cancer prevention trial

Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease

Association between sequence variants at 17q12 and 17q24.3 and prostate cancer risk in European and African Americans

Association between two unlinked loci at 8q24 and prostate cancer risk among European Americans.

Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer

Association of prostate cancer risk with SNPs in regions containing androgen receptor binding sites captured by ChIP-On-chip analyses

Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer

Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG

Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk

Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer

Comparison of two methods for estimating absolute risk of prostate cancer based on single nucleotide polymorphisms and family history

Comprehensive genetic evaluation of common E-cadherin sequence variants and prostate cancer risk: strong confirmation of functional promoter SNP.

Cumulative effect of five genetic variants on prostate cancer risk in multiple study populations

Estimation of absolute risk for prostate cancer using genetic markers and family history

Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer ⬇️

Family-based samples can play an important role in genetic association studies

Fine mapping association study and functional analysis implicate a SNP in MSMB at 10q11 as a causal variant for prostate cancer risk

Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11.

Generalizability of established prostate cancer risk variants in men of African ancestry

Genetic markers associated with early cancer-specific mortality following prostatectomy

Genetic variants and family history predict prostate cancer similar to prostate-specific antigen

Genetic variation in the upstream region of ERG and prostate cancer

Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21.

Genome-wide association study identifies a new locus JMJD1C at 10q21 that may influence serum androgen levels in men.

Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21.

Genome-wide copy-number variation analysis identifies common genetic variants at 20p13 associated with aggressiveness of prostate cancer

Genome-wide screen for prostate cancer susceptibility genes in men with clinically significant disease.

Genome‐wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families ⬇️

Germ-line sequence variants of PTEN do not have an important role in hereditary and non-hereditary prostate cancer susceptibility

Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death

Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk

Germline mutations in HOXB13 and prostate-cancer risk

H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer

Identification of a new prostate cancer susceptibility locus on chromosome 8q24.

Identification of a novel NBN truncating mutation in a family with hereditary prostate cancer ⬇️

Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families

Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients

Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer

Integration of multiethnic fine-mapping and genomic annotation to prioritize candidate functional SNPs at prostate cancer susceptibility regions

Interaction effect of PTEN and CDKN1B chromosomal regions on prostate cancer linkage

Interactions of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-like receptor 6-1-10 gene cluster increase prostate cancer risk

Key genes involved in the immune response are generally not associated with intraprostatic inflammation in men without a prostate cancer diagnosis: Results from the prostate cancer prevention trial

Large-scale association analysis in Asians identifies new susceptibility loci for prostate cancer

Large-scale fine mapping of the HNF1B locus and prostate cancer risk

MP69-12 ADDED VALUE OF GENETIC RISK SCORE TO THE PROSTATE CANCER PREVENTION TRIAL (PCPT) RISK CALCULATOR: FINDINGS FROM THE PCPT STUDY

Mutational analysis of PINX1 in hereditary prostate cancer.

Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: findings from the REDUCE trial

Prostate Cancer Susceptibility in Men of African Ancestry at 8q24

Prostate cancer risk-associated variants reported from genome-wide association studies: meta-analysis and their contribution to genetic Variation

Sequence variants in the 3'-->5' deoxyribonuclease TREX2: identification in a genetic screen and effects on catalysis by the recombinant proteins

Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study

Systematic replication study of reported genetic associations in prostate cancer: Strong support for genetic variation in the androgen pathway

The interaction of four genes in the inflammation pathway significantly predicts prostate cancer risk

Two independent prostate cancer risk-associated Loci at 11q13

Two susceptibility loci identified for prostate cancer aggressiveness

Two-locus genome-wide linkage scan for prostate cancer susceptibility genes with an interaction effect

Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG)

Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial